Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohnʼs disease: Results from CARE-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohnʼs disease: Results from CARE

Published:2012-01 Issue:1 Volume:18 Page:1-9
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Löfberg Robert,Louis Edouard V.,Reinisch Walter,Robinson Anne M.,Kron Martina,Camez Anne,Pollack Paul F.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference25 articles.

1. Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management

2. Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone

3. Inflammatory Bowel Disease

4. Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

5. Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment;Biomedicines;2024-08-13

2. Positioning Crohn’s Disease Therapies in the Era of Small Molecules and Combination Therapies;Current Gastroenterology Reports;2024-07-06

3. Specific Oral Manifestations in Adults with Crohn’s Disease;Journal of Clinical Medicine;2024-07-05

4. Initiation of vedolizumab did not provoke new‐onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24‐week study with imaging assessments;United European Gastroenterology Journal;2024-07-04

5. Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It;Cells;2024-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3